FoI Number
2022-728
Subject
Migraine
Date Received
09/02/2023
Request and Response

1. How many patients have been treated with the following drugs in the past 4 months:

  • Erenumab (Aimovig) - any disease                          5
  • Eptinezumab (Vyepti) - any disease                         0
  • Fremanezumab (Ajovy) - any disease                      0
  • Galcanezumab (Emgality) - any disease                  0
  • Botulinum Toxin (i.e., Botox, Dysport, Xeomin) - migraine ONLY

 NHS Shetland uses Xeomin but cannot identify who has it ONLY for Migraine

2. How many patients have you treated in the last 4 months for chronic migraine (15+ headache days per month) and episodic migraine (4-15 headache days per month) with the following drugs: 

Drugs

Chronic Migraine (15+ headache days per month)

Episodic Migraine (4-15 headache days per month)

Erenumab

 

 

Eptinezumab

 

 

Fremanezumab

 

 

Galcanezumab

 

 

Botulinum Toxin 

 

 

 

In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested. NHS Shetland does not collect this data.